The global spirometer market is expected to grow at a compound annual growth rate of 8.16% over the analyzed period to reach a market size of US$2.198 billion in 2026 from US$1.269 billion in 2019. Spirometers are apparatus that measures ventilation, i.e. the movement and volume of air inhaled and exhaled by human lungs to determine lungs health and the presence of diseases. Through the means of the spirometer, two types of ventilation abnormality, obstructive and restrictive can be located for timely treatment and better functioning. Surging causes of chronic obtrusive pulmonary diseases in the key driver of the market. Spirometers are used as diagnostic and therapeutic devices to treat pulmonary disease. Further, favorable government policies and rising health care expenditure will surge the demand for spirometers. Technological advancement opens new prospects for market growth.
Falling air quality has increased the cases of obstructive pulmonary diseases.
Degrading air quality is the prime reason for the rise in chronic obstructive pulmonary diseases (COPD) has had a blighting health effect. Data from World Health Organization states that, annually, 7 million people die from exposure to highly polluted air, stating that 9 out of every 10 people breathes polluted air. Further, air pollution causes 9% of annual deaths and is the prime cause of rising COPD among children and older generations. The reports extend that more than 3 million people die annually due to COPD with children at higher risk. Reports from the Indira Gandhi Institute of Medical Sciences (IGIMS) states that lung diseases have surged by 30% to 40% in the past decade and the leading cause is degrading air. Asthma is a leading cause of death, along with lung cancer and TB, afflicting 334 million people globally. Furthermore, the rising consumption of tobacco and cigarettes increases the tally of death.
Hence, the growing prevalence of COPD provides market growth prospects for the spirometer industry. Based on application, the spirometer market is segmented as diagnostic and therapeutic. The diagnostic application consists of observing the volume of air inhaled and exhaled to know whether the patient suffers from COPD. The therapeutic application, on the other hand, treats patients with COPD to improve lung air intake and out volume and hence is projected to hold dominating share of the market during the forecasted period. Increased awareness and better living standards have surged the therapeutic application of spirometers. Furthermore, improving healthcare infrastructure and services also contribute considerably to segment development.
Tabletop spirometers hold a significant market share of the global spirometer industry.
Based on the platform, the global spirometer market is divided into PC or Laptop, handheld, and table-top spirometers. PC or Laptop spirometers have a large influence on the market growth owing to more accurate results and technological advancement of such devices. The Tabletop spirometers, on the other hand, are calculated to grow at an auspicious rate during the forecasted period. Technological advancement in this segment will drive market growth. Cosmed, for instance, offers a tabletop spirometer with having an internal rechargeable battery, LCD screen, and inbuild thermal printer, and printing of pediatric incentivization graphics on the volume and flow, using PEF and FVC technology. Moreover, these spirometers do not require computer or power leads, making them unique. However, the presence of substitutes such as forced oscillation techniques may hinder the market prospects of this segment.
Hospitals and clinics will hold a dominating share of the market.
By end-users, the market is fragmented into hospitals, clinics, ambulatory care units, and households. The hospital and clinic demand for spirometers is speculated to dominate the market demand for spirometers during the forecasted period. Hospitals and clinics are industries where spirometers are used for both, diagnostic and therapeutic purposes. Increasing cases of COPD are driving the demand for spirometers for treatment in hospitals. Further, investment and infrastructure development in the healthcare segment supports the segment growth. The government of India, for instance, announced a 2.37times increase in the investment in the healthcare sector in Union Budget 2021-22 and US$87.85 billion were outlay to be invested in the sector in the next 6 years period, providing ample scope for the Indian spirometer market.
The North American region will have a humongous share in the global spirometer market while the Asia Pacific region will project huge growth prospects during the forecasted period.
Based on geography, the global spirometer market is divided into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific region. The North American region is projected to hold a humongous share of the spirometer market amid its state-of-art infrastructure facilities and high expenditure on the healthcare sector. The US Federal government is reported to spend around US$1.2 trillion on the healthcare sector in the year 2019, which is equivalent to 16.9% of the country’s GDP. While Canada spends 10.7% of its GDP on healthcare. Growth in the healthcare sector provides huge market prospects for the spirometer apparatus.
The Asia Pacific spirometer market, however, is anticipated to show considerable growth owing to rising expenditure on the healthcare sector, both by government and out-of-pockets. Further, degrading air quality in the region due to industrialization and urbanization has increased the cases of COPD and the demand for spirometers for diagnosis and treatment.
The coronavirus pandemic had a moderate impact on the spirometer market. A surge in the need for better healthcare to deal with the virus resulted in an increase in healthcare expenditure by the government, which expanded the market scope for spirometers. However, a surge in demand for oximeters, which is a close substitute for spirometers, has consumed a considerable market of spirometers which hinders their growth.
|The market size value in 2019||US$1.269 billion|
|The market size value in 2026||US$2.198 billion|
|Growth Rate||CAGR of 8.16% from 2019 to 2026|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Platform, Type, Technology, Application, End-Users, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Hill-Rom Services Inc., Schiller, SDI Diagnostics, Vitalograph, Jones Medical Instrument Company, MIR (Medical International Research), MGC Diagnostics, Geratherm Respiratory GmbH, NDD Medical Technologies|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for the spirometer market?
A1. The global spirometer market is expected to grow at a CAGR of 8.16% over the forecast period.
Q2. What is the size of global spirometer market?
A2. Spirometers Market was valued at US$1.269 billion in 2019.
Q3. Which region holds the largest market share in the spirometers market?
A3. The North American region is projected to hold a humongous share of the spirometer market amid its state-of-art infrastructure facilities and high expenditure on the healthcare sector.
Q4. What will be the spirometer market size by 2026?
A4. The global spirometer market is expected to reach a total market size of US$2.198 billion by 2026.
Q5. What factors are anticipated to drive the spirometers market growth?
A5. Surging causes of chronic obtrusive pulmonary diseases is the key driver of the spirometer market.